ZA957794B - [1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use - Google Patents
[1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and useInfo
- Publication number
- ZA957794B ZA957794B ZA957794A ZA957794A ZA957794B ZA 957794 B ZA957794 B ZA 957794B ZA 957794 A ZA957794 A ZA 957794A ZA 957794 A ZA957794 A ZA 957794A ZA 957794 B ZA957794 B ZA 957794B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- triazolo
- independently
- preparation
- pox
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106694 | 1994-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA957794B true ZA957794B (en) | 1996-05-14 |
Family
ID=8100607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA957794A ZA957794B (en) | 1994-09-16 | 1995-09-15 | [1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0781282B1 (cs) |
| JP (1) | JPH10506620A (cs) |
| KR (1) | KR970706285A (cs) |
| CN (1) | CN1193973A (cs) |
| AT (1) | ATE183186T1 (cs) |
| AU (1) | AU694554B2 (cs) |
| CA (1) | CA2200056A1 (cs) |
| CZ (1) | CZ284930B6 (cs) |
| DE (1) | DE69511420T2 (cs) |
| DK (1) | DK0781282T3 (cs) |
| ES (1) | ES2138233T3 (cs) |
| FI (1) | FI971076L (cs) |
| GR (1) | GR3031788T3 (cs) |
| HU (1) | HUT76802A (cs) |
| IL (1) | IL115299A0 (cs) |
| NO (1) | NO308797B1 (cs) |
| NZ (1) | NZ292108A (cs) |
| PL (1) | PL319175A1 (cs) |
| SK (1) | SK282457B6 (cs) |
| TW (1) | TW397835B (cs) |
| WO (1) | WO1996008493A1 (cs) |
| ZA (1) | ZA957794B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| TR200001728T2 (tr) | 1997-11-11 | 2000-09-21 | Ono Pharmaceutical Co., Ltd. | Birleşik pirazin türevleri |
| CA2754457A1 (en) | 2009-03-05 | 2010-09-10 | Astellas Pharma Inc. | Quinoxaline compounds |
| KR20130097178A (ko) | 2010-09-07 | 2013-09-02 | 아스텔라스세이야쿠 가부시키가이샤 | 퀴녹살린 화합물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
| AU3767793A (en) * | 1992-04-03 | 1993-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
| DK31093D0 (cs) * | 1993-03-19 | 1993-03-19 | Novo Nordisk As | |
| EP0698024B1 (en) * | 1993-05-06 | 1997-01-22 | Novo Nordisk A/S | [1,2,4]TRIAZOLO [4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE |
-
1995
- 1995-09-12 AT AT95930410T patent/ATE183186T1/de not_active IP Right Cessation
- 1995-09-12 KR KR1019970701669A patent/KR970706285A/ko not_active Ceased
- 1995-09-12 CZ CZ97753A patent/CZ284930B6/cs not_active IP Right Cessation
- 1995-09-12 FI FI971076A patent/FI971076L/fi unknown
- 1995-09-12 CA CA002200056A patent/CA2200056A1/en not_active Abandoned
- 1995-09-12 PL PL95319175A patent/PL319175A1/xx unknown
- 1995-09-12 CN CN95195697A patent/CN1193973A/zh active Pending
- 1995-09-12 SK SK334-97A patent/SK282457B6/sk unknown
- 1995-09-12 DK DK95930410T patent/DK0781282T3/da active
- 1995-09-12 ES ES95930410T patent/ES2138233T3/es not_active Expired - Lifetime
- 1995-09-12 NZ NZ292108A patent/NZ292108A/xx unknown
- 1995-09-12 DE DE69511420T patent/DE69511420T2/de not_active Expired - Fee Related
- 1995-09-12 AU AU33808/95A patent/AU694554B2/en not_active Ceased
- 1995-09-12 WO PCT/DK1995/000365 patent/WO1996008493A1/en not_active Ceased
- 1995-09-12 JP JP8509828A patent/JPH10506620A/ja active Pending
- 1995-09-12 EP EP95930410A patent/EP0781282B1/en not_active Expired - Lifetime
- 1995-09-12 TW TW084109492A patent/TW397835B/zh not_active IP Right Cessation
- 1995-09-12 HU HU9701241A patent/HUT76802A/hu unknown
- 1995-09-14 IL IL11529995A patent/IL115299A0/xx unknown
- 1995-09-15 ZA ZA957794A patent/ZA957794B/xx unknown
-
1997
- 1997-03-14 NO NO971187A patent/NO308797B1/no not_active IP Right Cessation
-
1999
- 1999-11-09 GR GR990402881T patent/GR3031788T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69511420D1 (de) | 1999-09-16 |
| IL115299A0 (en) | 1995-12-31 |
| EP0781282A1 (en) | 1997-07-02 |
| JPH10506620A (ja) | 1998-06-30 |
| CN1193973A (zh) | 1998-09-23 |
| KR970706285A (ko) | 1997-11-03 |
| NO971187D0 (no) | 1997-03-14 |
| AU694554B2 (en) | 1998-07-23 |
| FI971076A7 (fi) | 1997-05-13 |
| WO1996008493A1 (en) | 1996-03-21 |
| ES2138233T3 (es) | 2000-01-01 |
| TW397835B (en) | 2000-07-11 |
| SK282457B6 (sk) | 2002-02-05 |
| DK0781282T3 (da) | 2000-02-28 |
| SK33497A3 (en) | 1998-02-04 |
| NZ292108A (en) | 1999-02-25 |
| HUT76802A (en) | 1997-11-28 |
| DE69511420T2 (de) | 2000-03-30 |
| GR3031788T3 (en) | 2000-02-29 |
| NO308797B1 (no) | 2000-10-30 |
| NO971187L (no) | 1997-05-15 |
| FI971076A0 (fi) | 1997-03-14 |
| AU3380895A (en) | 1996-03-29 |
| CA2200056A1 (en) | 1996-03-21 |
| CZ284930B6 (cs) | 1999-04-14 |
| FI971076L (fi) | 1997-05-13 |
| PL319175A1 (en) | 1997-08-04 |
| ATE183186T1 (de) | 1999-08-15 |
| EP0781282B1 (en) | 1999-08-11 |
| CZ75397A3 (en) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700557A (es) | Dihidrobenzofuranos. | |
| AU3328499A (en) | Phthalazinone pde iii/iv inhibitors | |
| IL98559A0 (en) | Polycyclic guanine derivatives | |
| BG104996A (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| ATE179698T1 (de) | Pyrrolidin- und oxazolidin derivate , ihre herstellung und ihre verwendung als thrombocyten- aggregations-hemmer | |
| MX9702307A (es) | Pirrolo (2,3-d)pirimidinas y su uso. | |
| HUP9801704A2 (hu) | A protein tirozin-kináz által mediált sejtproliferáció gátlására szolgáló pirido[2,3-d]pirimidinek és ezeket tartalmazó gyógyszerkészítmények | |
| CY2365B1 (en) | Pyrrolopyrimidines and processes for the preparation thereof. | |
| YU19499A (sh) | Benzonaftiridini kao bronhijalni terapeutici | |
| DE60127845D1 (de) | Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel | |
| DE69316910D1 (de) | Neue vitamin d derivate | |
| DE59108419D1 (de) | Dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide | |
| SI0920426T1 (en) | New thiazole derivatives with phosphodiesterase-inhibiting effect | |
| IL150329A0 (en) | 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity | |
| IL115299A0 (en) | Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use | |
| MX9701949A (es) | Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales. | |
| ATE374189T1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| CA2120782A1 (en) | Thioxanthenone antitumor agents | |
| TR200100133T2 (tr) | FKBP İnhibitörleri | |
| TW334340B (en) | Preparation for pyrazolyl derivatives | |
| CA2070120A1 (en) | Thioxanthenone antitumor agents | |
| AU3380795A (en) | {1,2,4}triazolo{4,3-a}quinoxalinone derivatives, their preparation and use | |
| TR199801683A2 (xx) | Yeni �re t�revleri. | |
| DE60003560D1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| TW251282B (en) | Nonsteroidal triazole antiinflammatory agents |